Literature DB >> 17215484

Inhibition of a protein-protein interaction between INI1 and c-Myc by small peptidomimetic molecules inspired by Helix-1 of c-Myc: identification of a new target of potential antineoplastic interest.

L Bagnasco1, L Tortolina, B Biasotti, N Castagnino, R Ponassi, V Tomati, E Nieddu, G Stier, D Malacarne, S Parodi.   

Abstract

c-Myc is a transcription modulator proto-oncogene. When overexpressed, it becomes an important contributor to the multi-hit process of malignant transformation. In two earlier papers in this journal (see refs. 19 , 20) we reported that retro-inverso peptidomimetic molecules inspired by the Helix-1 of c-Myc motif could be sequence-specific antiproliferative agents active in the low micromolar range. We also found that our peptides were not opening the four-alpha-helix Myc:Max bundle. Their antiproliferative activity in cancer cell lines needs the presence of side chains projecting outside of the bundle in the corresponding native H1 motif. This observation suggested interference with an external partner. In this study we investigated the INI1:Myc interaction. INI1 is a subunit of the SWI/SNF complex (component of the enhanceosome surrounding Myc:Max heterodimer). The INI1:Myc interaction was confirmed via pull down, ELISA, and fluorescence anisotropy assays. According to the length of INI1 fragments used, we calculated Kds ranging between 1.3x10(-6) and 4.8x10(-7) M. The three different techniques applied showed that the INI1:Myc interaction was also the target of our retro-inverso peptidomimetic molecules, which seem to bind specifically at INI1. A Myc binding, 21aa INI1 fragment (minimum interacting sequence), could inspire the synthesis of a new class of more selective c-Myc inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215484     DOI: 10.1096/fj.06-7082com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

Review 1.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Involvement of the N-terminal B-box domain of Arabidopsis BBX32 protein in interaction with soybean BBX62 protein.

Authors:  Qungang Qi; Ann Gibson; Xiaoran Fu; Meiying Zheng; Rosemarie Kuehn; Yongcheng Wang; Yanfei Wang; Santiago Navarro; James A Morrell; Dongming Jiang; Grant Simmons; Erin Bell; Natalia B Ivleva; Amanda L McClerren; Paul Loida; Thomas G Ruff; Marie E Petracek; Sasha B Preuss
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

Review 3.  Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept.

Authors:  Vladimir N Uversky
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

4.  Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.

Authors:  Samantha Gadd; Simone Treiger Sredni; Chiang-Ching Huang; Elizabeth J Perlman
Journal:  Lab Invest       Date:  2010-03-08       Impact factor: 5.662

5.  Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma.

Authors:  Deepti Soodgupta; Dipanjan Pan; Grace Cui; Angana Senpan; Xiaoxia Yang; Lan Lu; Katherine N Weilbaecher; Edward V Prochownik; Gregory M Lanza; Michael H Tomasson
Journal:  Mol Cancer Ther       Date:  2015-03-30       Impact factor: 6.261

Review 6.  Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery.

Authors:  Dipanjan Pan; Christine T N Pham; Katherine N Weilbaecher; Michael H Tomasson; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-08-21

Review 7.  MYC-Master Regulator of the Cancer Epigenome and Transcriptome.

Authors:  Candace J Poole; Jan van Riggelen
Journal:  Genes (Basel)       Date:  2017-05-13       Impact factor: 4.096

8.  Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.

Authors:  Alison K Esser; Michael H Ross; Francesca Fontana; Xinming Su; Ariel Gabay; Gregory C Fox; Yalin Xu; Jingyu Xiang; Anne H Schmieder; Xiaoxia Yang; Grace Cui; Michael Scott; Samuel Achilefu; Jay Chauhan; Steven Fletcher; Gregory M Lanza; Katherine N Weilbaecher
Journal:  Theranostics       Date:  2020-06-12       Impact factor: 11.556

9.  PHF10 subunit of PBAF complex mediates transcriptional activation by MYC.

Authors:  N V Soshnikova; E V Tatarskiy; V V Tatarskiy; N S Klimenko; A A Shtil; M A Nikiforov; S G Georgieva
Journal:  Oncogene       Date:  2021-08-31       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.